Source: sales, EvaluatePharma; journal, Kantar Media | *journal data run from January 2016-October 2016
From the January 01, 2017 Issue of MM+M - Medical Marketing and Media
The top-selling heart drug is Merck's Zetia, which is expected to bring in about $1.68 billion in sales in 2016.
Source: sales, EvaluatePharma; journal, Kantar Media | *journal data run from January 2016-October 2016
From the January 01, 2017 Issue of MM+M - Medical Marketing and Media
Get the most out of
Register for free and enjoy unlimited access to: